(Q31954450)
Statements
A phase II/III clinical study of tin ethyl etiopurpurin (Purlytin)-induced photodynamic therapy for the treatment of recurrent cutaneous metastatic breast cancer (English)
Mang TS
Allison R
Hewson G
Snider W
1 November 1998